Related Experiment Video
Updated: Jun 23, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
[Endoscopy in patients receiving anticoagulation or antiplatelet therapy]
Jens Kjeldsen1, Torsten Pless, Søren Meisner
1Endoskopiudvalget under Dansk Gastroenterologisk Selskab Odense Universitetshospital, Medicinsk Gastroenterologisk Afdeling S og Kirurgisk Afdeling A, Køge Sygehus, DK-4600 Køge.
Abstract:
Drugs that interfere with haemostasis are widely used for thromboembolic diseases and cardiovascular protection. Gastrointestinal bleeding is a well-known complication, and endoscopists are often faced with decisions concerning the safety of endoscopic procedures in these patients. Based on expert opinion and on data from observational studies, we suggest algorithms for the approach to acute and elective procedures based on procedural risk and on risks for thromboembolic episodes.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Venous Thrombosis IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Endoscopic Procedures I: Esophagogastroduodenoscopy
During an EGD, the endoscope can be used to:
